Company Quick10K Filing
Solbright
10-Q 2019-11-30 Filed 2020-01-22
10-Q 2019-08-31 Filed 2019-10-15
10-K 2019-05-31 Filed 2019-09-13
10-Q 2019-02-28 Filed 2019-05-20
10-Q 2018-11-30 Filed 2019-04-15
10-Q 2018-08-31 Filed 2018-10-19
10-K 2018-05-31 Filed 2018-09-18
10-Q 2018-02-28 Filed 2018-04-20
S-1 2018-02-27 Public Filing
10-Q 2017-11-30 Filed 2018-01-16
10-Q 2017-08-31 Filed 2017-10-24
10-K 2017-05-31 Filed 2017-09-14
10-Q 2017-02-28 Filed 2017-04-21
10-Q 2016-11-30 Filed 2017-01-23
10-Q 2016-08-31 Filed 2016-10-17
10-K 2016-05-31 Filed 2016-09-21
10-Q 2016-02-29 Filed 2016-04-20
10-Q 2015-11-30 Filed 2016-01-19
10-Q 2015-08-31 Filed 2015-10-15
10-K 2015-05-31 Filed 2015-08-27
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-14
10-K 2014-05-31 Filed 2014-08-27
10-Q 2014-02-28 Filed 2014-04-14
10-Q 2013-11-30 Filed 2014-01-15
10-Q 2013-08-31 Filed 2013-10-11
10-Q 2013-02-28 Filed 2013-09-16
10-Q 2012-11-30 Filed 2013-09-13
10-Q 2012-08-31 Filed 2013-09-12
10-K 2012-05-31 Filed 2013-08-30
10-Q 2011-02-28 Filed 2011-04-19
10-Q 2010-11-30 Filed 2011-01-12
10-Q 2010-08-31 Filed 2010-10-19
10-K 2010-05-31 Filed 2010-09-14
10-Q 2010-02-28 Filed 2010-04-02
8-K 2020-08-31
8-K 2020-06-30
8-K 2020-05-08
8-K 2020-05-04
8-K 2020-04-24
8-K 2020-04-14
8-K 2020-03-04
8-K 2019-12-31
8-K 2019-12-09
8-K 2019-11-15
8-K 2019-05-20
8-K 2019-03-07
8-K 2019-01-08
8-K 2018-11-26
8-K 2018-10-31
8-K 2018-10-01
8-K 2018-09-05
8-K 2018-07-30
8-K 2018-06-28
8-K 2018-05-31
8-K 2018-04-30

Solbright Financials

SBRT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash511809234512631143119123010235291263956621110470827226114726891,311789
Accounts Receivable3020221326113420919222322121,0861,0891,0041,98716184548582507
Inventory157344294971201418162000
PP&E88877727262423222013,92313,98713,884
Assets511809234516132365130127217553872750338358552343024419,01619,17318,23618,87915,67015,03119,87321,83112,978
Accounts Payable1,4881,5031,5046436192963913963873754974647018327507839218146482,1472,7693,0583,7773,7772,98412,38610,28314,136
Long-Term Debt6001404084661,2491,4490004574574574572,0002,0002,0002,00017975,22777,119
Liabilities9,2979,3449,3749,4179,5549,6969,4019,6304,2513,2783,3383,1573,7882,1302,1491,9262,1392,3642,3872,02713,00315,3279,84910,81811,2516,38398,575103,103107,736
Stockholders' Equity-9,292-9,344-9,194-9,324-9,209-9,535-9,078-9,565-4,121-3,152-3,317-3,082-3,250-1,402-1,646-1,544-1,554-1,841-1,958-1,7836,0133,8468,3868,0614,4198,647-78,702-81,272-94,758
Income Statement ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue0000000401191422231078157492004243902741,2695,2783,2912,4978457431,892
Cost of Revenue000000005353723380267519704,4963,6891,5691,5771,0356991,028737
Gross Profit0000000028037719744131212299782-398928-581-19045864-1,118
R&D000374161057552886013298186272794114400302681,4411,366
SG&A40161091932224372771,3011,1871,1645752,2365297812822,1103136243052,3121,5781,5501,5352,9741,7634,7292,8844,241
Tax000000000-360000000121-1200000000
Net Income-51-30-151-285-325-549-48762,5511,300200-597-2,293-529-69561-1,947-287-509-272-2,280-3,809-2,897-2,442-6,657-5,057-17,180-13,604-17,451
Cash Flow ($'000)2012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating6-108-219-216-267-195-123-30-235-447-25631-3-20152-349-730730-36338-2,370-5,599-2,499
Cash Investing000000-190-3,000-5-5000-13-109
Cash Financing-10200400020004046050300201501641484,189-368347702,3286,2342,085